22 federal suits filed over hormone replacement drugs West Virginia Record, WV - Nov 29, 2008 "The WHI and NCI studies released in July 2002 changed the way doctors and scientists viewed estrogen - not only does estrogen hormone therapy fail to ...
Advances in hormone replacement therapy: making the menopause... 7thSpace Interactive (press release), NY - Nov 27, 2008 Methods: the importance of the results of some large, randomized controlled trials (RCTs) on Hormone Replacement Therapy (HRT) has modified the risk/benefit ...
Second Opinion Financial Times, UK - By Margaret Mccartney When I was at medical school, hormone replacement therapy was not just the treatment of choice for the flushes and sweats of menopause...
Why some early breast cancers may spontaneously disappear CTV.ca, Canada - Moreover, with the widespread discontinuance of hormone replacement therapy (HRT) for menopausal symptoms, the incidence of breast cancer world-wide has ...
Learned This Week Vancouver Sun, Canada - Nov 29, 2008 Hormone therapy could accentuate certain pre-existing heart disease risk factors and a heart health evaluation should become the norm when considering ...
ABC News Medical Contributor ABC News - Aug 4, 2008 Hormone replacement therapy may not be as risky as thought for those in early menopause, researchers say. A new study from Kaiser Permanente, presented at ...
Hargrove speaker for MRH luncheon program Wednesday Columbia Daily Herald, TN - 41 minutes ago Dr. Joel Hargrove, a board certified gynecologist, will discuss menopause and hormone replacement therapy. Menopause is a natural part of the aging process ...
Breast cancer: What you need to know Food Consumer, IL - Hormone therapy: In a monograph published on July 29, the International Agency for Research on Cancer concluded that estrogen-progestogen hormone...
Treating menopause poses quite a dilemma Daily Press, VA - Aug 2, 2008 A study presented at the British Menopause Society conference last month says taking menopausal hormone therapy can reduce a woman's risk of developing ...
NAMS position statement on HT and menopause updated Endocrine Today, NJ - Jul 31, 2008 The North American Menopause Society addresses the risk-benefit analysis and therapeutic issues of menopausal hormone therapy. The North American Menopause...
The Estrogen Elixir: A History of Hormone Replacement Therapy in ... Journal of American Medical Association (subscription), IL - Jul 15, 2008 By ES Watkins More than 50 million American women, 1 both proponents and opponents of menopausal hormone therapy, can quickly appreciate the value of The ...
Early detection can be a lifesaver Columbus Ledger-Enquirer, GA - Jul 27, 2008 The male hormone testosterone provides the cancer with the means to grow and thrive. My only treatment option is hormonal therapy, which means I will be ...
Source: Google News
Postmenopausal Hormone Therapy and Mortality. - F Grodstein, MJ Stampfer, GA Colditz, WC Willett, … - Obstetrical & Gynecological Survey, 1997 - obgynsurvey.com ... November 1997pp 695-697. Postmenopausal HormoneTherapy and Mortality.
[Gynecology: Menopause]. Grodstein, Francine; Stampfer, Meir ...
The menopause GA GREENDALE, NP LEE, ER ARRIOLA - Lancet(British edition), 1999 - cat.inist.fr ... between menopause and several symptoms and diseases are proposed. The evidence for
these associations varies and is reviewed. Hormone replacement therapy can ...
Risk of Venous Thromboembolism in Users of Hormone Replacement Therapy. - E Daly, MP Vessey, MM Hawkins, JL Carson, P Gough, … - Obstetrical & Gynecological Survey, 1997 - obgynsurvey.com ... Sex Steroids Used in Hormonal Treatment Increase Vascular ... oral estrogen-progestin
replacement therapy: effects on ... Role of Hormone Replacement Therapy in Cancer ...
The U.S. Food and Drug Administration has approved the Berlex Inc. drug Angeliq (drospirenone and estradiol) as a form of hormone-replacement therapy for moderate-to-severe menopausal symptoms, according to a company statement issued Thursday.
The active ingredient drospirenone, already found in the company's Yasmin oral contraceptive approved in 2001, acts as a mild diuretic, the company said. Berlex said it is studying whether it could help reduce blood pressure in menopausal women with hypertension.
The estrogen component is estradiol, the same estrogen produced by the ovaries prior to menopause, the company said.
Women with liver, kidney or adrenal disease shouldn't take Angeliq, and patients on drugs that increase body levels of potassium should ask their doctor before beginning Angeliq, Berlex said.
Since 2002, when a major U.S. study found that women taking HRT had a higher incidence of heart attacks, strokes, blood clots and breast cancer, doctors have been asked to prescribe drugs containing estrogen at the lowest effective doses and for the shortest duration possible. Estrogen therapy shouldn't be used by women with undiagnosed abnormal vaginal bleeding or a suspected or known history of breast cancer, Berlex said.
To learn more about hormone replacement therapy, visit Medline Plus.
High Blood Pressure Can Be Lethal in Overweight
September 29, 2005 08:41:08 PM PST
A major longitudinal study confirms what experts have long suspected: High blood pressure is key to the increased risk of fatal heart attack and stroke in overweight and obese people.
In the study, French researchers tracked the health of more than 240,000 people for an average of 14 years.
"We observed that cardiovascular risk is not clearly increased unless hypertension is present in these overweight and obese subjects," Dr. Athanase Benetos, of the Medical School of Nancy, said in a prepared statement. "In our population, the presence of hypertension was the most important factor that led to increased cardiovascular disease mortality among overweight subjects."
The researchers also found that:
Overweight men and women who had high blood pressure faced double the risk for fatal heart attack or stroke of overweight people with normal blood pressure.
Overweight women who had high blood pressure and diabetes were at more than four times the risk of cardiovascular death and overweight men with high blood pressure had triple the risk, compared to women and men with normal weight and normal blood pressure.
Overweight people with diabetes and normal blood pressure weren't at increased risk of cardiovascular death. Overweight men with high cholesterol were at a slightly increased risk of cardiovascular death, but that was not the case for women.
The best way to reduce the risk of cardiovascular death in overweight and obese people with high blood pressure is treatment that targets both blood pressure and weight, Benetos said.
The study was published in a recent issue of Hypertension.
